2014
DOI: 10.1371/journal.pone.0102605
|View full text |Cite
|
Sign up to set email alerts
|

Intact Dendritic Cell Pathogen-Recognition Receptor Functions Associate with Chronic Hepatitis C Treatment-Induced Viral Clearance

Abstract: Although studies have addressed the exhaustion of the host's immune response to HCV and its role in treatment, there is little information about the possible contribution of innate immunity to treatment-induced clearance. We hypothesized that because intact myeloid dendritic cell (MDC) pathogen sensing functions are associated with improved HCV-specific CD8+ T cell functionality in some chronically infected patients, it might enhance HCV clearance rate under standard interferon therapy. To investigate this hyp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…Maintenance of normal dendritic cell (DC) phenotypes and functional repertoires has been shown to be critical for sustained antiviral responses and is necessary to augment antiviral therapies, including alpha interferon (IFN-␣), which can block GBV-B infection in vitro (27)(28)(29). Conversely, GBV-B has evolved to inhibit IFN-␣ production, and HCV has similarly developed mechanisms to subvert plasmacytoid (pDCs) and myeloid (mDCs) DCs, decreasing the levels of IFN-␣, interleukin-10 (IL-10), and IL-12 (30)(31)(32), all of which are necessary for initiation of T cell responses and mobilization of natural killer (NK) cells.…”
mentioning
confidence: 99%
“…Maintenance of normal dendritic cell (DC) phenotypes and functional repertoires has been shown to be critical for sustained antiviral responses and is necessary to augment antiviral therapies, including alpha interferon (IFN-␣), which can block GBV-B infection in vitro (27)(28)(29). Conversely, GBV-B has evolved to inhibit IFN-␣ production, and HCV has similarly developed mechanisms to subvert plasmacytoid (pDCs) and myeloid (mDCs) DCs, decreasing the levels of IFN-␣, interleukin-10 (IL-10), and IL-12 (30)(31)(32), all of which are necessary for initiation of T cell responses and mobilization of natural killer (NK) cells.…”
mentioning
confidence: 99%